Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ACTRN12626000267358) titled 'Colchicine with Antibiotics for Respiratory Exacerbations (CARE) in children with bronchiectasis' on March 3.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Primary Sponsor: Queensland University of Technology
Condition:
Bronchiectasis
Bronchiectasis
Respiratory - Other respiratory disorders / diseases
Intervention:
Oral colchicine tablets 0.5 mg once daily for 14 days in all children
Adherence to trial medication will be monitored via medication logs and return of medication packaging at end of day 14.
In addition ...